PYC Therapeutics Limited (AU:PYC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PYC Therapeutics Limited is gearing up to host an informative investor webinar on the 30th of August 2024, aiming to share the company’s advancements achieved in the current year. The clinical-stage biotech firm, known for developing novel RNA therapies for genetic diseases, has multiple clinical trials underway and is preparing for a new trial in early 2025. Interested shareholders can join the event either in person in Western Australia or through a provided online link.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.